- $705.67m
- $519.06m
- $342.39m
Annual income statement for Ibotta, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 211 | 320 | 367 | 342 |
| Cost of Revenue | ||||
| Gross Profit | 165 | 276 | 317 | 271 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 251 | 264 | 349 | 343 |
| Operating Profit | -40.3 | 56 | 18.2 | -0.934 |
| Total Net Non Operating Interest Income / Expense | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -54.6 | 44.1 | 24.5 | 9.85 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -54.9 | 38.1 | 68.7 | 3.58 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -54.9 | 38.1 | 68.7 | 3.58 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -54.9 | 38.1 | 68.7 | 3.58 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -1.7 | 1.27 | 2.81 | 0.179 |